MARK3 and cancer: Further analysis demonstrated that microtubule affinity regulating kinase 3 (MARK3), a microtubule-binding kinase and regulator of microtubule dynamics, is directly deubiquitinated by USP21, leading to KRAS-independent growth, cancer development, and macropinocytosis, a key metabolism mechanism for KRASmu PDAC cell survival.